twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2005
vol. 107
 
Share:
Share:
abstract:
Review paper

Are endothelin-1 and neuropeptide Y involved in the pathogenesis of glaucoma?

Barbara Terelak-Borys
1

  1. Klinika Okulistyki Centrum Medycznego Kształcenia Podyplomowego SPSK im. prof. W. Orłowskiego w Warszawie
Klinika Oczna 2005, 107(4-6): 306-311
Online publish date: 2005/07/02
View full text Get citation
 
Vasospasm in the vessels, supporting the optic disc, is nowadays considered one of the possible etiological factors leading to development of glaucomatous neuropathy. This article describes physiological regulatory mechanisms of blood circulation in these vessels, including influence of autonomic nervous system and blood flow autoregulation; it also explains why vasospasm may disturb autoregulation. Special attention is paid to the role of vascular endothelial mediators, which are responsible for autoregulation. Observations indicating that vasospasm may be a risk factor of glaucomatous damage are also presented. The article describes data concerning vasospastic effects of two mediators: endothelin-1 (ET-1), released by vascular endothelium, and neuropeptide Y (NPY), a sympathetic nervous system neurotransmitter, on the vessels supporting the optic disc and their possible role in producing blood flow disturbances in these vessels. Investigation results indicating that endothelial dysfunction, connected with increased ET-1 plasma levels and sympathetic nervous system disorders, may be involved in the pathogenesis of normal-tension glaucoma, are presented.
keywords:

endothelin-1 (ET-1), neuropeptide (NPY), vasospasm, primary open-angle glaucoma, normal-tension glaucoma

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.